产品
编 号：F349347
分子式：C15H14ClNOS
分子量：291.8
分子式：C15H14ClNOS
分子量：291.8
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
结构图
CAS No: 40312-34-3
产品详情
生物活性：
Adenosine A1 receptor activator T62 is an allosteric enhancer of adenosine A1 receptor. Adenosine A1 receptor activator T62 produces antinociception in animal models of acute pain and also reduces hypersensitivity in models of inflammatory and nerve-injury pain.
体内研究：
Adenosine A1 receptor activator T62 (0.3-3 μg; intrathecal administration; male SpragueDawley rats) treatment produces a dose-dependent antihypersensitivity effect, with no effect on ambulation or activity level.Animal Model:Male SpragueDawley rats (250 g) after paw incision surgery
Dosage:0.3 μg, 0.5 μg, 1 μg, and 3 μg
Administration:Intrathecal administration
Result:Produced a dose-dependent antihypersensitivity effect, with no effect on ambulation or activity level. The ED40 (95% confidence interval) was 0.77 (0.63-0.91) μg.
Adenosine A1 receptor activator T62 is an allosteric enhancer of adenosine A1 receptor. Adenosine A1 receptor activator T62 produces antinociception in animal models of acute pain and also reduces hypersensitivity in models of inflammatory and nerve-injury pain.
体内研究：
Adenosine A1 receptor activator T62 (0.3-3 μg; intrathecal administration; male SpragueDawley rats) treatment produces a dose-dependent antihypersensitivity effect, with no effect on ambulation or activity level.Animal Model:Male SpragueDawley rats (250 g) after paw incision surgery
Dosage:0.3 μg, 0.5 μg, 1 μg, and 3 μg
Administration:Intrathecal administration
Result:Produced a dose-dependent antihypersensitivity effect, with no effect on ambulation or activity level. The ED40 (95% confidence interval) was 0.77 (0.63-0.91) μg.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备